Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
1.050
-0.060 (-5.41%)
At close: Mar 27, 2026, 4:00 PM EDT
1.055
+0.005 (0.47%)
After-hours: Mar 27, 2026, 6:17 PM EDT

Jasper Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
50.971.6486.8938.2584.719.84
Cash & Short-Term Investments
50.971.6486.8938.2584.719.84
Cash Growth
-44.98%-17.55%127.16%-54.84%326.96%1535.78%
Other Receivables
---0.66-0.6
Total Trade Receivables
---0.66-0.6
Other Current Assets
3.674.172.052.823.130.25
Total Current Assets
54.5675.8188.9441.7387.8320.69
Net Property, Plant & Equipment
2.342.854.195.454.832.03
Other Long-Term Assets
0.571.241.761.180.990.64
Total Assets
57.4779.994.8948.3693.6523.36
Accounts Payable
9.174.034.151.773.921.42
Accrued Expenses
10.1710.127.254.433.62.6
Current Portion of Leases
1.71.090.970.870.51-
Total Current Liabilities
21.0415.2412.377.078.024.01
Long-Term Leases
-0.721.812.792.381.62
Other Long-Term Liabilities
24.862.262.262.5213.749.01
Total Long-Term Liabilities
24.862.994.085.3116.1210.64
Total Liabilities
45.918.2316.4512.3724.1414.65
Common Stock
000000
Additional Paid-in Capital
319.14302.54248.04141.12136.961.68
Retained Earnings
-307.57-240.87-169.6-105.14-67.45-36.81
Total Common Shareholders' Equity
11.5761.6778.4435.9969.52-35.13
Minority Interest
-----43.84
Shareholders' Equity
11.5761.6778.4435.9969.52-35.13
Total Liabilities & Equity
57.4779.994.8948.3693.6523.36
Total Debt
1.71.812.793.652.891.62
Net Cash (Debt)
49.269.8284.134.681.8218.21
Net Cash Growth
-29.54%-16.98%143.07%-57.71%349.19%1401.87%
Net Cash Per Share
3.174.798.069.4871.8129.73
Book Value
11.5761.6778.4435.9969.52-35.13
Book Value Per Share
0.754.237.519.8761.01-57.35
Tangible Book Value
11.5761.6778.4435.9969.52-35.13
Tangible Book Value Per Share
0.754.237.519.8761.01-57.35
Updated Nov 10, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q